DNAmito enables precise cancer treatment through its proprietary DNA technology and cloud platform. Our products leverage existing and open standards in the industry. DNAmito is vendor agnostic. ...
Bellwether Bio is a Seattle-based startup developing a novel bioinformatics approach to analyze circulating cell-free DNA. First unveiled in a January 2016 Cell paper, technology was
Biovica, a Swedish biotech company founded in 2009, develops and commercializes blood-based biomarker assays that improve the monitoring of modern cancer therapies and better predict patient ...
Blue Earth Diagnostics is a molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management and guide care for ...
CDx Diagnostics® provides clinicians with unique tools to enhance their detection of precancerous change through more complete epithelial sampling combined with computer-assisted morphological and ...
Cleveland Diagnostics is developing a breakthrough technology to discover new class of diagnostics tests with high sensitivity and specificity for many cancers
Clinical Genomics is committed to developing and delivering solutions that provide physicians and their patients with information to help guide earlier and better treatment decisions in cancer ...
Cynvenio is a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood.
Creates diagnostic kits for complex DNA testing within oncology, reproductive health and hereditary diseases. Our products are used to guide targeted cancer therapies, to enable rapid prenatal ...
Molecular Diagnostics. Develops and commercializes innovative molecular diagnostic tests that address unmet needs in cancer screening, diagnosis and patient management.
Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease.
Freenome is using advanced computer learning to enable earlier, more effective treatment for millions of patients. The company is developing computational methods to create effective tools for ...
Genome Explorations, a subsidiary of Compass Laboratory Services, LLC., is a premier research institution providing global genomic profiling and molecular diagnostics. We serve academic centers, ...
GoPath Laboratories is a state-of-the-art CAP-accredited, CLIA-certified molecular diagnostic laboratory providing anatomic pathology, hematopathology, and hereditary cancer testing for clinicians ...
HalioDx utilizes a proprietary set of Immune biomarkers, advanced image analysis technologies and a unique know-how to develop, manufacture and commercialize immune-based diagnostics services and ...
At Inspirata®, our focus is to advance the practice of pathology with solutions leveraging 21st century tools and technologies that are purpose built to accelerate cancer ...
ITUS Corporation funds, develops, acquires, and licenses emerging technologies in the areas of biotechnology. The Company offers a platform for inexpensive, non-invasive, and blood tests for early ...
MEDITE® Group is a medical technology company specializing in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment ...
Metabiomics is developing a non-invasive stool test for the early detection of colon polyps and colorectal cancer based an advanced interrogation of the human gut microbiome
NantOmics employs a comprehensive, integrated panomic approach to detect molecular alterations in individual tumors and inform personalized treatment options for patients with cancer. Whole genome ...
Founded in 2011, NovellusDX has brought together a team of skilled individuals from several fields, including synthetic biology, functional genomics, bioinformatics, engineering, algorithm ...
OmniSeq was created from the Center for Personalized Medicine at Roswell Park Cancer Institute and is a CLIA and NYS CLEP licensed molecular laboratory that is committed to improving access to the ...
Oncimmune is a leading early cancer detection company. It has pioneered the development of autoantibody assay technologies that have the potential to allow cancer detection up to four years ...
OncoDNA offers solutions combining the most relevant molecular technologies in order to provide a comprehensive characterization of the patient’s cancer, hence supporting oncologists in their ...
Launched in 2013, Oncospire was established as an equally owned joint venture between Cancer Genetics, Inc. and Mayo Clinic. Focussed on developing and commercializing next generation sequencing ( ...
Orbit Genomics was founded to accelerate precision medicine through its analysis and exploitation of the hidden genome. The company uses microsatellite genotyping to enable precision lung cancer ...
OTraces has developed a blood-based disease testing platform that uses math- and physics-based noise suppression techniques never before employed in human disease testing, and has thereby achieved ...
Precipio Diagnostics develops the ICE COLD-PCR (Ice Cold PCR) technology, claimed to preferentially enrich mutant DNA sequences in an excess of wild-type DNA through selective amplification of the ...
Resolution Bioscience uses Next Generation DNA sequencing, bioinformatics, and biochemistry to measure circulating, cell-free DNA (cfDNA) for cancer diagnostics and monitoring.
SkylineDx is dedicated to optimize therapeutic decision making through the development of molecular diagnostic tests for blood cancers and thereby improving the quality of life of blood cancer ...
ThyroSeq is a joint partnership between University of Pittsburgh Medical Center and CBLPath. The partnership markets a Next Generation Sequencing test known as ThyroSeq, a custom panel designed ...
TOMA has commercially launched TOMA OS-SeqTM Cancer Assay to help laboratories and researchers uncover clinically meaningful genomic changes in tumors, including many missed by other ...
